Pall 10-Q 2 Jun 14 2014 Q3 Quarterly report Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION	9 Months Ended
	Apr. 30, 2014	27-May-14
Entity Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Apr-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'PALL CORP	'
Entity Central Index Key	'0000075829	'
Current Fiscal Year End Date	'--07-31	'
Entity Well-known Seasoned Issuer	'Yes	'
Entity Voluntary Filers	'No	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	109,681,236

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$870,874	$936,886
Accounts receivable	564,782	566,335
Inventory	428,648	381,047
Prepaid expenses	80,676	72,808
Other current assets	82,368	92,953
Total current assets	2,027,348	2,050,029
Property, plant and equipment	799,197	774,948
Goodwill	445,030	342,492
Intangible assets	211,586	137,243
Other non-current assets	163,104	168,127
Total assets	3,646,265	3,472,839
Current liabilities:	'	'
Notes payable	304,959	169,967
Accounts payable	160,049	157,176
Accrued liabilities	307,930	312,829
Income taxes payable	57,009	60,732
Current portion of long-term debt	406	420
Dividends payable	30,159	27,947
Total current liabilities	860,512	729,071
Long-term debt, net of current portion	463,666	467,319
Income taxes payable – non-current	135,366	141,843
Deferred taxes and other non-current liabilities	365,551	319,650
Total liabilities	1,825,095	1,657,883
Stockholders’ equity:	'	'
Common stock, par value $.10 per share	12,796	12,796
Capital in excess of par value	324,025	298,150
Retained earnings	2,424,552	2,285,031
Treasury stock, at cost	-950,506	-740,229
Accumulated other comprehensive income/(loss):	'	'
Foreign currency translation	130,928	84,598
Pension liability adjustment	-125,257	-125,211
Unrealized investment gains	1,525	2,123
Unrealized gains/(losses) on derivatives	3,107	-2,302
Total accumulated other comprehensive income/(loss)	10,303	-40,792
Total stockholders’ equity	1,821,170	1,814,956
Total liabilities and stockholders’ equity	$3,646,265	$3,472,839

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Apr. 30, 2014	Jul. 31, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, par value per share (in dollars per share)	$0.10	$0.10

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$682,445	$641,190	$1,989,193	$1,931,245
Cost of sales	334,371	307,111	971,146	928,120
Gross profit	348,074	334,079	1,018,047	1,003,125
Selling, general and administrative expenses	201,045	199,595	592,228	601,569
Research and development	26,644	22,608	74,890	68,582
Restructuring and other charges, net	11,542	12,824	29,910	21,497
Interest expense, net	4,747	5,298	15,919	10,747
Earnings from continuing operations before income taxes	104,096	93,754	305,100	300,730
Provision for income taxes	15,405	19,483	61,230	56,975
Net earnings from continuing operations	88,691	74,271	243,870	243,755
Earnings/(loss) from discontinued operations, net of income taxes	0	-1,206	0	245,552
Net earnings	$88,691	$73,065	$243,870	$489,307
Earnings per share from continuing operations:	'	'	'	'
Basic (in dollars per share)	$0.80	$0.66	$2.20	$2.16
Diluted (in dollars per share)	$0.80	$0.65	$2.17	$2.13
Earnings/(loss) per share from discontinued operations:	'	'	'	'
Basic (in dollars per share)	$0	($0.01)	$0	$2.17
Diluted (in dollars per share)	$0	($0.01)	$0	$2.15
Earnings per share:	'	'	'	'
Basic (in dollars per share)	$0.80	$0.65	$2.20	$4.33
Diluted (in dollars per share)	$0.80	$0.64	$2.17	$4.28
Dividends declared per share	$0.55	$0.25	$0.83	$0.75
Average shares outstanding:	'	'	'	'
Basic	110,183	111,964	110,946	112,979
Diluted	111,466	113,311	112,215	114,415

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net earnings	$88,691	$73,065	$243,870	$489,307
Other comprehensive income/(loss), net of income taxes:	'	'	'	'
Foreign currency translation	25,041	-33,127	46,330	8,195
Pension liability adjustment	619	4,199	-46	8,762
Unrealized investment gains/(losses)	-224	-208	-598	-145
Unrealized gains/(losses) on derivatives	-172	1,548	5,409	-2,229
Total other comprehensive income/(loss), net of income taxes	25,264	-27,588	51,095	14,583
Comprehensive income	$113,955	$45,477	$294,965	$503,890

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013
Operating activities:	'	'
Net cash provided by operating activities	$342,164	$206,890
Investing activities:	'	'
Capital expenditures	-50,301	-66,387
Acquisition of businesses, net of cash acquired	-195,262	0
Purchases of retirement benefit assets	-29,518	-33,503
Proceeds from retirement benefit assets	36,020	36,689
Proceeds from sale of assets	5,618	537,284
Other	-9,167	-3,862
Net cash provided/(used) by investing activities	-242,610	470,221
Financing activities:	'	'
Notes payable	134,992	10,020
Dividends paid	-88,596	-80,197
Long-term borrowings	0	14
Repayments of short-term debt	-3,927	0
Repayments of long-term debt	-545	-352
Net proceeds from stock plans	13,814	31,054
Additions to deferred financing costs	0	3,043
Purchase of treasury stock	-250,000	-250,000
Excess tax benefits from stock-based compensation arrangements	11,327	11,774
Net cash used by financing activities	-182,935	-280,730
Cash flow for period	-83,381	396,381
Cash and cash equivalents at beginning of year	936,886	500,274
Effect of exchange rate changes on cash and cash equivalents	17,369	7,312
Cash and cash equivalents at end of period	870,874	903,967
Supplemental disclosures:	'	'
Interest paid	13,068	23,780
Income taxes paid (net of refunds)	$44,782	$133,417

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION
	The condensed consolidated financial information of Pall Corporation and its subsidiaries (hereinafter collectively called the “Company”) included herein is unaudited. Such information reflects all adjustments of a normal recurring nature, which are, in the opinion of Company management, necessary to present fairly the Company’s consolidated financial position, results of operations and cash flows as of the dates and for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2013 (“2013 Form 10-K”).
	As discussed in Note 16, Discontinued Operations, on August 1, 2012, the Company sold certain assets of its blood collection, filtration and processing product line, which was a component of the Company’s Life Sciences segment, and met the criteria for discontinued operations and held for sale presentation during the third quarter of fiscal year 2012. As such, it has been reported as a discontinued operation in the Company’s condensed consolidated financial statements for all periods presented.

BALANCE_SHEET_DETAILS

BALANCE SHEET DETAILS	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BALANCE SHEET DETAILS	'
	BALANCE SHEET DETAILS
	The following tables provide details of selected balance sheet items:
		Apr 30, 2014			Jul 31, 2013
	Accounts receivable:
	Billed	$	513,137		$	508,448
	Unbilled	65,661			72,787
	Total	578,798			581,235
	Less: Allowances for doubtful accounts	(14,016		)	(14,900		)
		$	564,782		$	566,335
	Unbilled receivables principally relate to revenues accrued for long-term contracts recorded under the percentage-of-completion method of accounting.
		Apr 30, 2014			Jul 31, 2013
	Inventory:
	Raw materials and components	$	124,837		$	94,837
	Work-in-process	109,028			94,998
	Finished goods	194,783			191,212
		$	428,648		$	381,047
		Apr 30, 2014			July 31, 2013
	Property, plant and equipment:
	Property, plant and equipment	$	1,757,331		$	1,650,274
	Less: Accumulated depreciation and amortization	(958,134		)	(875,326		)
		$	799,197		$	774,948

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS	9 Months Ended
	Apr. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
GOODWILL AND INTANGIBLE ASSETS	'
	GOODWILL AND INTANGIBLE ASSETS
	The Company completed its annual goodwill impairment test for all reporting units in the third quarter of fiscal year 2014 and determined that no impairment existed. In addition, the Company had no impairment of goodwill in the prior year. In connection with the annual goodwill impairment test, the Company estimates the fair value of its reporting units using a market approach employing Level 3 inputs as defined in the fair value hierarchy described in Note 11, Fair Value Measurements.
	The following table presents changes in the carrying value of goodwill, allocated by reportable segment.
		Life Sciences		Industrial		Total
	Balance as of July 31, 2013	$	180,896	$	161,596	$	342,492
	Acquisitions	99,744		—		99,744
	Foreign currency translation	1,818		976		2,794
	Balance as of April 30, 2014	$	282,458	$	162,572	$	445,030
	In connection with the acquisitions in the first nine months of fiscal year 2014, see Note 17, Acquisitions, the Company recorded the fair value of the intangible assets acquired, which were valued using the income approach. The valuation employed level 3 inputs, as defined in the fair value hierarchy.
	Intangible assets consist of the following:
		Apr 30, 2014
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	166,112	$	64,522	$	101,590
	Customer-related intangibles	129,777		30,480		99,297
	Trademarks	16,412		6,835		9,577
	Other	3,674		2,552		1,122
		$	315,975	$	104,389	$	211,586
		Jul 31, 2013
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	123,707	$	69,992	$	53,715
	Customer-related intangibles	97,016		22,425		74,591
	Trademarks	13,291		6,166		7,125
	Other	4,425		2,613		1,812
		$	238,439	$	101,196	$	137,243
	Amortization expense from continuing operations for intangible assets for the three and nine months ended April 30, 2014 was $5,399 and $14,778, respectively. Amortization expense from continuing operations for intangible assets for the three and nine months ended April 30, 2013 was $4,765 and $14,900, respectively. Amortization expense is estimated to be approximately $5,699 for the remainder of fiscal year 2014, $21,202 in fiscal year 2015, $19,920 in fiscal year 2016, $19,841 in fiscal year 2017, $19,670 in fiscal year 2018, and $17,316 in fiscal year 2019.

TREASURY_STOCK

TREASURY STOCK	9 Months Ended
	Apr. 30, 2014
Stockholders' Equity Note [Abstract]	'
TREASURY STOCK	'
	TREASURY STOCK
	The following table highlights the share repurchase authorizations in effect during fiscal year 2014:
		Date of Authorization
		26-Sep-11			17-Jan-13			Total
	Amount available for repurchases as of July 31, 2013	$	81,873		$	250,000		$	331,873
	New authorizations	—			—			—
	Utilized	(81,873		)	(168,127		)	(250,000		)
	Amount available for repurchases as of April 30, 2014	$	—		$	81,873		$	81,873
	The Company’s shares may be purchased over time as market and business conditions warrant. There is no time restriction on these authorizations. In September 2013, the Company entered into an Accelerated Share Repurchase (“ASR”) agreement with a third-party financial institution to repurchase $125,000 of the Company’s common stock. This transaction was completed in the second quarter of fiscal year 2014. Under the agreement, the Company paid $125,000 to the financial institution. Upon completion of the transaction, the Company received a total of 1,573 shares with an average price per share of $79.45.
	In December 2013, the Company entered into a second ASR agreement with a third-party financial institution to repurchase $125,000 of the Company’s common stock. This transaction was completed in the third quarter of fiscal year 2014. Under the agreement, the Company paid $125,000 to the financial institution. Upon completion of the transaction, the Company received a total of 1,483 shares with an average price per share of $84.31.
	During the nine months ended April 30, 2014, 935 shares were issued under the Company’s stock-based compensation plans. At April 30, 2014, the Company held 18,291 treasury shares.

CONTINGENCIES_AND_COMMITMENTS

CONTINGENCIES AND COMMITMENTS	9 Months Ended
	Apr. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
CONTINGENCIES AND COMMITMENTS	'
	CONTINGENCIES AND COMMITMENTS
	With respect to the matters described in Note 14, Contingencies and Commitments, to the Company’s consolidated financial statements included in the Company’s 2013 Form 10-K and below, the Company has assessed the ultimate resolution of these matters and has reflected appropriate contingent liabilities in the condensed consolidated financial statements as of April 30, 2014 and July 31, 2013.
	The Company and its subsidiaries are subject to certain other legal actions that arise in the normal course of business. Other than those legal proceedings and claims discussed in the 2013 Form 10-K and this Note, the Company is not facing any other legal proceedings and claims that would individually or in the aggregate have a reasonably possible material adverse effect on its financial condition or operating results. As such, any reasonably possible loss or range of loss, other than those legal proceedings discussed in the 2013 Form 10-K and this Note, is immaterial. However, the results of legal proceedings cannot be predicted with certainty. If the Company failed to prevail in several of these legal matters in the same reporting period, the operating results of a particular reporting period could be materially adversely affected.
	Environmental Matters:
	With respect to the environmental matters at the Company’s Pinellas Park, Florida site, previously disclosed in Note 14, Contingencies and Commitments, to the Company’s consolidated financial statements included in the Company’s 2013 Form 10-K, the Florida Department of Environmental Protection approved the remedial action plan in September 2013. As a result of this, the Company added $4,440 to its environmental reserves in the first quarter of fiscal year 2014.
	The Company’s condensed consolidated balance sheet at April 30, 2014 includes liabilities for environmental matters of approximately $20,738 which relate primarily to the environmental proceedings discussed in the 2013 Form 10-K and as updated in this Note. In the opinion of management, the Company is in substantial compliance with applicable environmental laws and its current accruals for environmental remediation are adequate. However, as regulatory standards under environmental laws are becoming increasingly stringent, there can be no assurance that future developments, additional information and experience gained will not cause the Company to incur material environmental liabilities or costs beyond those accrued in its condensed consolidated financial statements.

RESTRUCTURING_AND_OTHER_CHARGE

RESTRUCTURING AND OTHER CHARGES, NET	9 Months Ended
	Apr. 30, 2014
Restructuring and Related Activities [Abstract]	'
RESTRUCTURING AND OTHER CHARGES, NET	'
	RESTRUCTURING AND OTHER CHARGES, NET
	The following tables summarize the restructuring and other charges (“ROTC”) recorded in the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended Apr 30, 2014									Nine Months Ended Apr 30, 2014
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	8,289		$	—		$	8,289		$	18,751		$	(402	)	$	18,349
	Professional fees and other costs, net of receipt of insurance claim payments	567			1,498			2,065			2,704			3,693			6,397
	(Gain)/loss on sale and impairment of assets, net	3,986			(1,640		)	2,346			3,986			(1,480		)	2,506
	Environmental matters	—			—			—			—			4,440			4,440
	Reversal of excess restructuring reserves	(1,158		)	—			(1,158		)	(1,782		)	—			(1,782		)
		$	11,684		$	(142	)	$	11,542		$	23,659		$	6,251		$	29,910
	Cash	$	7,698		$	(142	)	$	7,556		$	19,673		$	6,091		$	25,764
	Non-cash	3,986			—			3,986			3,986			160			4,146
		$	11,684		$	(142	)	$	11,542		$	23,659		$	6,251		$	29,910
		Three Months Ended Apr 30, 2013									Nine Months Ended Apr 30, 2013
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	5,701		$	1,452		$	7,153		$	10,896		$	2,903		$	13,799
	Professional fees and other costs, net of receipt of insurance claim payments	361			531			892			1,149			2,117			3,266
	(Gain)/loss on sale and impairment of assets, net	999			1,357			2,356			993			1,357			2,350
	Environmental matters	—			2,715			2,715			—			2,715			2,715
	Reversal of excess restructuring reserves	(292		)	—			(292		)	(633		)	—			(633		)
		$	6,769		$	6,055		$	12,824		$	12,405		$	9,092		$	21,497
	Cash	$	5,770		$	4,185		$	9,955		$	11,007		$	6,709		$	17,716
	Non-cash	999			1,870			2,869			1,398			2,383			3,781
		$	6,769		$	6,055		$	12,824		$	12,405		$	9,092		$	21,497
	(1) Restructuring:
	In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential.
	Key components of the structural cost improvement initiative include:
	•	the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,
	•	creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,
	•	reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and
	•	reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.
	Restructuring charges recorded in the three and nine months ended April 30, 2014 and April 30, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.
	Restructuring charges in the three and nine months ended April 30, 2014 also includes the impairment of assets of $3,986 related to the discontinuance of a specific manufacturing line due to excess capacity as a result of recent acquisitions.
	(2) Other (Gains)/Charges:
	Severance benefits and other employment contract obligations: In the three and nine months ended April 30, 2013, the Company recorded charges related to certain employment contract obligations.
	Professional fees and other: In the three months ended April 30, 2014, the Company recorded costs related to the settlement of a legal matter. Furthermore, in the three and nine months ended April 30, 2014, the Company recorded acquisition related legal and other professional fees. In the three and nine months ended April 30, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K).
	Gain on sale and impairment of assets: In the three months ended April 30, 2014, the Company recorded a gain on the sale of a building in Europe. In the three months ended April 30, 2013, the Company recorded an impairment related to a software project.
	Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the nine months ended April 30, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida. In the three months ended April 30, 2013, the Company increased its previously established environmental reserve related to a matter in Glen Cove, New York.
	The following table summarizes the activity related to restructuring liabilities recorded for the Company’s structural cost improvement initiative which began in fiscal year 2012:
		Severance			Other			Total
	Original charge	$	61,852		$	3,448		$	65,300
	Utilized	(27,365		)	(2,798		)	(30,163		)
	Translation	(123		)	(47		)	(170		)
	Balance at Jul 31, 2012	$	34,364		$	603		$	34,967
	Additions	21,637			2,840			24,477
	Utilized	(29,574		)	(1,936		)	(31,510		)
	Reversal of excess reserves	(500		)	(57		)	(557		)
	Translation	313			23			336
	Balance at Jul 31, 2013	$	26,240		$	1,473		$	27,713
	Additions	18,751			2,704			21,455
	Utilized	(18,996		)	(2,533		)	(21,529		)
	Reversal of excess reserves	(1,682		)	(100		)	(1,782		)
	Translation	628			63			691
	Balance at Apr 30, 2014	$	24,941		$	1,607		$	26,548
	Excluded from the table above are restructuring liabilities relating to restructuring plans initiated in fiscal year 2010. At April 30, 2014, the balance of these liabilities was $213.

INCOME_TAXES

INCOME TAXES	9 Months Ended
	Apr. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The Company’s effective tax rates on continuing operations for the nine months ended April 30, 2014 and April 30, 2013 were 20.1% and 18.9%, respectively. For the nine months ended April 30, 2014, the effective tax rate varied from the U.S. federal statutory rate primarily due to the benefits of foreign operations and a net tax benefit of $10,054 from the resolution of tax audits. For the nine months ended April 30, 2013, the effective tax rate varied from the U.S. federal statutory rate primarily due to the benefits of foreign operations and a net tax benefit of $7,757 primarily from the resolution of a U.S. tax audit partly offset by the establishment of deferred tax liabilities for the repatriation of foreign earnings.
	During the nine months ended April 30, 2014, the Company reached a final settlement with Her Majesty’s Revenue and Customs (“HMRC”) in the United Kingdom resolving the outstanding tax positions for fiscal years ended July 2010 and July 2011. As a result, the Company reversed $10,961 of previously recorded liabilities related to tax and penalties, as well as $1,478 related to interest ($1,138 net of income tax cost) that were accrued but not assessed as part of the settlement.
	During the nine months ended April 30, 2013, the Company reached a final agreement with the Internal Revenue Service (“IRS”) resolving the outstanding tax positions for fiscal years ended 2006 through 2008. As a result, the Company reversed $10,193 of previously recorded liabilities related to tax and penalties, as well as $6,704 related to interest ($4,268 net of income tax cost) that were accrued but not assessed as part of the IRS agreement.
	At April 30, 2014 and July 31, 2013, the Company had gross unrecognized income tax benefits of $198,899 and $203,376, respectively. During the nine months ended April 30, 2014, the amount of gross unrecognized tax benefits decreased by $4,477, primarily due to the settlement with HMRC for fiscal years ended July 2010 and July 2011 and the expiration of various foreign statutes of limitation, partially offset by tax positions taken during the current period and the impact of foreign currency translation. As of April 30, 2014, the amount of net unrecognized income tax benefits that, if recognized, would impact the effective tax rate was $155,469.
	At April 30, 2014 and July 31, 2013, the Company had liabilities of $17,450 and $18,622, respectively, for potential payment of interest and penalties.
	Due to the potential resolution of tax examinations and the expiration of various statutes of limitation, the Company believes that it is reasonably possible that the gross amount of unrecognized tax benefits may decrease within the next twelve months by a range of zero to $55,781.
	Subsequent to the balance sheet date, the Company received official notification of the resolution of a tax audit in Germany related to fiscal years 2005 through 2008. This will result in the recognition of previously unrecognized income tax benefits of approximately $7,000 and a reversal of interest of approximately $3,000 in the Company's fourth fiscal quarter ending July 31, 2014.

COMPONENTS_OF_NET_PERIODIC_PEN

COMPONENTS OF NET PERIODIC PENSION COST	9 Months Ended
	Apr. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
COMPONENTS OF NET PERIODIC PENSION COST	'
	COMPONENTS OF NET PERIODIC PENSION COST
	Net periodic pension benefit cost for the Company’s defined benefit pension plans includes the following components:
		Three Months Ended
		U.S. Plans						Foreign Plans						Total
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013
	Service cost	$	2,169		$	2,648		$	1,005		$	1,093		$	3,174		$	3,741
	Interest cost	3,028			2,617			4,398			3,899			7,426			6,516
	Expected return on plan assets	(2,325		)	(2,383		)	(3,611		)	(3,937		)	(5,936		)	(6,320		)
	Amortization of prior service cost/(credit)	395			392			(10		)	(12		)	385			380
	Amortization of actuarial loss	1,344			2,411			1,450			1,358			2,794			3,769
	Loss due to curtailments and settlements	—			16			—			—			—			16
	Net periodic benefit cost	$	4,611		$	5,701		$	3,232		$	2,401		$	7,843		$	8,102
		Nine Months Ended
		U.S. Plans						Foreign Plans						Total
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013
	Service cost	$	6,509		$	7,943		$	2,998		$	3,443		$	9,507		$	11,386
	Interest cost	9,083			7,852			12,923			11,965			22,006			19,817
	Expected return on plan assets	(6,974		)	(7,150		)	(10,591		)	(12,158		)	(17,565		)	(19,308		)
	Amortization of prior service cost/(credit)	1,185			1,178			(31		)	(44		)	1,154			1,134
	Amortization of actuarial loss	4,033			7,233			4,261			4,170			8,294			11,403
	Loss due to curtailments and settlements	—			49			—			—			—			49
	Net periodic benefit cost	$	13,836		$	17,105		$	9,560		$	7,376		$	23,396		$	24,481

STOCKBASED_PAYMENT

STOCK-BASED PAYMENT	9 Months Ended
	Apr. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
STOCK-BASED PAYMENT	'
	STOCK–BASED PAYMENT
	The Company currently has four stock-based employee and director compensation award types (Restricted Stock Unit, Stock Option Plans, Management Stock Purchase Plan (“MSPP”), and Employee Stock Purchase Plan (“ESPP”)), which are more fully described in Note 15, Common Stock, to the consolidated financial statements included in the 2013 Form 10-K.
	The detailed components of stock-based compensation expense recorded in the condensed consolidated statements of earnings for the three and nine months ended April 30, 2014 and April 30, 2013 are reflected in the table below:
		Three Months Ended				Nine Months Ended
		Apr 30, 2014		Apr 30, 2013		Apr 30, 2014		Apr 30, 2013
	Restricted stock units	$	5,064	$	3,978	$	15,511	$	11,895
	Stock options	2,069		1,825		5,555		4,503
	MSPP	961		976		2,125		2,763
	ESPP	273		302		771		992
	Total	$	8,367	$	7,081	$	23,962	$	20,153

EARNINGS_PER_SHARE

EARNINGS PER SHARE	9 Months Ended
	Apr. 30, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	EARNINGS PER SHARE
	The condensed consolidated statements of earnings present basic and diluted earnings per share. Basic earnings per share is determined by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share considers the potential effect of dilution on basic earnings per share assuming potentially dilutive shares that meet certain criteria, such as those issuable upon exercise of stock options, were outstanding. The treasury stock method reduces the dilutive effect of potentially dilutive securities as it assumes that any cash proceeds (from the issuance of potentially dilutive securities) are used to buy back shares at the average share price during the period. Equity awards aggregating 496 and 742 shares were not included in the computation of diluted shares for the three months ended April 30, 2014 and April 30, 2013, respectively, because their effect would have been antidilutive. For the nine months ended April 30, 2014 and April 30, 2013, 524 and 586 antidilutive shares, respectively, were excluded. The following is a reconciliation between basic shares outstanding and diluted shares outstanding:
		Three Months Ended		Nine Months Ended
		Apr 30, 2014	Apr 30, 2013	Apr 30, 2014	Apr 30, 2013
	Basic shares outstanding	110,183	111,964	110,946	112,979
	Effect of stock plans	1,283	1,347	1,269	1,436
	Diluted shares outstanding	111,466	113,311	112,215	114,415

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Apr. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	FAIR VALUE MEASUREMENTS
	The Company records certain of its financial assets and liabilities at fair value, which is the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.
	The current authoritative guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Authoritative guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	•	Level 1: Use of observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	•	Level 2: Use of inputs other than quoted prices included in Level 1, which are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	•	Level 3: Use of inputs that are unobservable.
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of April 30, 2014:
		Fair Value Measurements
		As of
		Apr 30, 2014		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	3,948	$	3,948	$	—	$	—
	Available-for-sale securities:
	Equity securities	4,524		4,524		—		—
	Debt securities:
	Corporate	30,359		—		30,359		—
	U.S. Treasury	10,416		—		10,416		—
	Federal agency	16,374		—		16,374		—
	Mortgage-backed	9,544		—		9,544		—
	Trading securities	788		788		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	3,555		—		3,555		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	689		—		689		—
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of July 31, 2013:
		Fair Value Measurements
		As of
		Jul 31, 2013		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	6,404	$	6,404	$	—	$	—
	Available-for-sale securities:
	Equity securities	176		176		—		—
	Debt securities:
	Corporate	32,393		—		32,393		—
	U.S. Treasury	11,543		—		11,543		—
	Federal agency	20,642		—		20,642		—
	Mortgage-backed	5,990		—		5,990		—
	Trading securities	190		190		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	301		—		301		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	3,066		—		3,066		—
	The Company’s money market funds and equity securities are valued using quoted market prices and, as such, are classified within Level 1 of the fair value hierarchy.
	The fair value of the Company’s investments in debt securities are valued utilizing third party pricing services and verified by management. The pricing services use inputs to determine fair value which are derived from observable market sources including reportable trades, benchmark curves, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events. These investments are included in Level 2 of the fair value hierarchy.
	The fair values of the Company’s foreign currency forward contracts are valued using pricing models, with all significant inputs derived from or corroborated by observable market data such as yield curves, currency spot and forward rates, and currency volatilities. These investments are included in Level 2 of the fair value hierarchy.

INVESTMENT_SECURITIES

INVESTMENT SECURITIES	9 Months Ended
	Apr. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
INVESTMENT SECURITIES	'
	INVESTMENT SECURITIES
	The following is a summary of the Company’s available-for-sale investment securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets. Contractual maturity dates of debt securities held by the benefits protection trusts at April 30, 2014 range from 2014 to 2046.
		Cost/			Fair Value			Gross		Gross			Net Unrealized
		Amortized						Unrealized		Unrealized			Holding
		Cost Basis						Holding		Holding			Gains/(Losses)
								Gains		Losses
	April 30, 2014
	Equity securities	$	5,029		$	4,524		$	5	$	(510	)	$	(505	)
	Debt securities:
	Corporate	29,435			30,359			1,172		(248		)	924
	U.S. Treasury	10,310			10,416			215		(109		)	106
	Federal agency	16,075			16,374			878		(579		)	299
	Mortgage-backed	9,366			9,544			189		(11		)	178
		$	70,215		$	71,217		$	2,459	$	(1,457	)	$	1,002
	July 31, 2013
	Equity securities	$	176		$	176		$	—	$	—		$	—
	Debt securities:
	Corporate	31,546			32,393			1,274		(427		)	847
	U.S. Treasury	11,339			11,543			294		(90		)	204
	Federal agency	19,810			20,642			1,131		(299		)	832
	Mortgage-backed	5,752			5,990			238		—			238
		$	68,623		$	70,744		$	2,937	$	(816	)	$	2,121
	The following table shows the gross unrealized losses and fair value of the Company’s available-for-sale investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:
		Less than 12 months						12 months or greater					Total
		Fair			Gross			Fair		Gross			Fair			Gross
		Value			Unrealized			Value		Unrealized			Value			Unrealized
					Holding					Holding						Holding
					Losses					Losses						Losses
	April 30, 2014
	Debt securities:
	Corporate	$	8,865		$	(248	)	$	—	$	—		$	8,865		$	(248	)
	U.S. Treasury	4,372			(109		)	—		—			4,372			(109		)
	Federal agency	1,634			(63		)	1,598		(516		)	3,232			(579		)
	Mortgage-backed	1,109			(11		)	—		—			1,109			(11		)
	Equity securities	4,326			(510		)	—		—			4,326			(510		)
		$	20,306		$	(941	)	$	1,598	$	(516	)	$	21,904		$	(1,457	)
		Less than 12 months						12 months or greater					Total
		Fair			Gross			Fair		Gross			Fair			Gross
		Value			Unrealized			Value		Unrealized			Value			Unrealized
					Holding					Holding						Holding
					Losses					Losses						Losses
	July 31, 2013
	Debt securities:
	Corporate	$	10,990		$	(427	)	$	—	$	—		$	10,990		$	(427	)
	U.S. Treasury	3,778			(90		)	—		—			3,778			(90		)
	Federal agency	3,701			(299		)	—		—			3,701			(299		)
		$	18,469		$	(816	)	$	—	$	—		$	18,469		$	(816	)
	The following table shows the proceeds and gross gains and losses from the sale of available-for-sale investments for the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended						Nine Months Ended
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014		Apr 30, 2013
	Proceeds from sales	$	4,915		$	883		$	7,973	$	13,169
	Realized gross gains on sales	93			18			177		370
	Realized gross losses on sales	6			—			106		5
	The following is a summary of the Company’s trading securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets.
		Apr 30, 2014			Jul 31, 2013
	Equity securities	$	788		$	190
	Total trading securities	$	788		$	190
	The following table shows the net gains and losses recognized on trading securities for the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended						Nine Months Ended
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014		Apr 30, 2013
	Gains/(losses), net recognized for securities held	$	(1	)	$	—		$	22	$	—
	Gains/(losses), net recognized for securities sold	—			—			—		—
	Total gains/(losses), net recognized	$	(1	)	$	—		$	22	$	—

DERIVATIVE_INSTRUMENTS_AND_HED

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Apr. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
	The Company manages certain financial exposures through a risk management program that includes the use of foreign exchange derivative financial instruments. Derivatives are executed with counterparties with a minimum credit rating of “A” by Standard & Poors and “A2” by Moody’s Investor Services, in accordance with the Company’s policies. The Company does not utilize derivative instruments for trading or speculative purposes. As of April 30, 2014, the Company had foreign currency forward contracts outstanding with notional amounts aggregating $512,733, whose fair values were a net asset of $2,866.
	Foreign Exchange Related:
	a. Derivatives Not Designated as Hedging Instruments
	The risk management objective of holding foreign exchange derivatives is to mitigate volatility to earnings and cash flows due to changes in foreign exchange rates. The Company and its subsidiaries conduct transactions in currencies other than their functional currencies. These transactions include non-functional intercompany and external sales as well as intercompany and external purchases. The Company uses foreign exchange forward contracts, matching the notional amounts and durations of the receivables and payables resulting from the aforementioned underlying foreign currency transactions, to mitigate the exposure to earnings and cash flows caused by the changes in fair value of these receivables and payables from fluctuating foreign exchange rates. The notional amount of foreign currency forward contracts not designated as hedging instruments entered into during the three and nine months ended April 30, 2014 was $664,039 and $1,845,481, respectively. The notional amount of foreign currency forward contracts outstanding that were not designated as hedging instruments as of April 30, 2014 was $406,572.
	b. Cash Flow Hedges
	The Company uses foreign exchange forward contracts for cash flow hedging on its future transactional exposure to the Euro due to changes in market rates to exchange Euros for British Pounds. The hedges cover a British subsidiary (British Pound functional) with Euro revenues and a Swiss subsidiary (Euro functional) with British Pound expenses. The probability of the occurrence of these transactions is high and the Company’s assessment is based on observable facts including the frequency and amounts of similar past transactions. The objective of the cash flow hedges is to lock a portion of the British Pound equivalent amount of Euro sales for the British subsidiary and a portion of the Euro equivalent amount of British Pound expenses for the Swiss subsidiary at the agreed upon exchange rates in the foreign exchange forward contracts. The notional amount of foreign currency forward contracts designated as hedging instruments entered into during the three and nine months ended April 30, 2014 was $23,174 and $77,941. The notional amount of foreign currency forward contracts outstanding designated as hedging instruments as of April 30, 2014 was $106,161 and covers certain monthly transactional exposures through May 2015.
	c. Net Investment Hedges
	The risk management objective of designating the Company’s foreign currency loan as a hedge of a portion of its net investment in a wholly owned Japanese subsidiary is to mitigate the change in the fair value of the Company’s net investment due to changes in foreign exchange rates. The Company uses a JPY loan outstanding to hedge its equity of the same amount in the Japanese wholly owned subsidiary. The hedge of net investment consists of a JPY 9 billion loan.
	The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows:
		Asset Derivatives						Liability Derivatives
	April 30, 2014	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	2,895			Other current liabilities		$	7
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	660			Other current liabilities		$	682
	Total derivatives			$	3,555					$	689
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	87,687
		Asset Derivatives						Liability Derivatives
	July 31, 2013	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	—			Other current liabilities		$	1,941
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	301			Other current liabilities		$	1,125
	Total derivatives			$	301					$	3,066
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	91,800
	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Three Months Ended										Three Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	305			$	1,548			Net sales		$	440		$	(615	)
										Cost of sales		171			(537		)
	Total derivatives	$	305			$	1,548					$	611		$	(1,152	)
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Nine Months Ended										Nine Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	5,615			$	(2,229	)		Net sales		$	552		$	(1,002	)
										Cost of sales		(695		)	(707		)
	Total derivatives	$	5,615			$	(2,229	)				$	(143	)	$	(1,709	)
	(a)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.
	The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
				Amount of Gain or (Loss) Recognized in
				Earnings on Derivatives
				Three Months Ended								Nine Months Ended
		Location of Gain or (Loss) Recognized in Earnings on Derivatives		Apr 30, 2014				Apr 30, 2013				Apr 30, 2014			Apr 30, 2013
	Derivatives not designated as hedging relationships
	Foreign exchange forward contracts	Selling, general and administrative expenses		$	(607	)		$	(5,206	)		$	(2,950	)	$	(15,032	)
	The amounts of the gains and losses related to the Company’s nonderivative financial instruments designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Three Months Ended										Three Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	63			$	4,320			N/A		$	—		$	—
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
(Effective Portion)							from Accumulated	(Effective Portion) (b)
							OCI into Earnings
							(Effective Portion)
	Nine Months Ended										Nine Months Ended
	Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
Nonderivatives designated as hedging relationships
Net investment hedge	$	(4,113	)		$	14,757			N/A		$	—		$	—
(b)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)	9 Months Ended
	Apr. 30, 2014
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)	'
	ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)
	Changes in accumulated other comprehensive income by component are presented below:
		Foreign Currency Translation			Defined Benefit Pension Plan			Unrealized investment gains/(losses)			Unrealized gains/(losses) on derivatives			Accumulated other comprehensive income/(loss)
	Balance at July 31, 2013	$	84,598		$	(125,211	)	$	2,123		$	(2,302	)	$	(40,792	)
	Other comprehensive income/(loss) before reclassifications	46,330			—			(813		)	5,154			50,671
	Amounts reclassified from accumulated other comprehensive income (loss)	—			6,551			215			255			7,021
	Foreign exchange adjustments and other	—			(6,597		)	—			—			(6,597		)
	Balance at April 30, 2014	$	130,928		$	(125,257	)	$	1,525		$	3,107		$	10,303
	Reclassifications out of accumulated other comprehensive income are presented below:
		Three Months Ended			Nine Months Ended			Affected line item in the Condensed Consolidated Statement of Earnings
		Apr 30, 2014			Apr 30, 2014
	Defined Benefit Pension Plan
	Amortization of prior service cost	$	(385	)	$	(1,154	)	Note (a)
	Recognized actuarial gain/(loss)	(2,794		)	(8,294		)	Note (a)
	Total before tax	(3,179		)	(9,448		)
	Tax (expense)/benefit	958			2,897
	Net of tax	$	(2,221	)	$	(6,551	)
	Unrealized investment gains/(losses)
	Realized investment gain/(losses)	$	(217	)	$	(336	)	Selling, general and administrative
	Tax (expense)/benefit	78			121
	Net of tax	$	(139	)	$	(215	)
	Unrealized gains/(losses) on derivatives
	Foreign exchange forward contracts	$	440		$	552		Sales
	Foreign exchange forward contracts	171			(695		)	Cost of sales
	Total before tax	611			(143		)
	Tax (expense)/benefit	(102		)	(112		)
	Net of tax	$	509		$	(255	)
	(a)	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Apr. 30, 2014
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	SEGMENT INFORMATION
	The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.
	The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and nine months ended April 30, 2014 and April 30, 2013.
		Three Months Ended				Nine Months Ended
		Apr 30, 2014		Apr 30, 2013		Apr 30, 2014		Apr 30, 2013
	SALES:
	Life Sciences	$	368,835	$	326,097	$	1,041,011	$	955,230
	Industrial	313,610		315,093		948,182		976,015
	Total	$	682,445	$	641,190	$	1,989,193	$	1,931,245
	SEGMENT PROFIT:
	Life Sciences	$	88,339	$	81,195	$	252,240	$	233,514
	Industrial	49,350		45,853		146,723		146,723
	Total segment profit	137,689		127,048		398,963		380,237
	Corporate Services Group	17,304		15,172		48,034		47,263
	ROTC	11,542		12,824		29,910		21,497
	Interest expense, net	4,747		5,298		15,919		10,747
	Earnings from continuing operations before income taxes	$	104,096	$	93,754	$	305,100	$	300,730

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	9 Months Ended
	Apr. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
DISCONTINUED OPERATIONS	'
	DISCONTINUED OPERATIONS
	On April 28, 2012, the Company entered into an asset purchase agreement (“APA”) to sell certain assets of its blood collection, filtration and processing product line (the “Product Line”) to Haemonetics Corporation (“Haemonetics”) for approximately $550,000. The transaction involved the transfer of manufacturing facilities and equipment in Covina, California; Tijuana, Mexico; Ascoli, Italy and a portion of the Company’s operations in Fajardo, Puerto Rico. In addition to the manufacturing facilities and related equipment, the Company transferred Product Line related inventory and intangible assets. Haemonetics also assumed certain employee-related liabilities. The sale closed on August 1, 2012, and approximately 1,400 employees transitioned to Haemonetics at that time.
	Separate from these manufacturing facilities, the Company also agreed to transfer related blood media manufacturing capabilities and assets to Haemonetics. The transfer of the related media lines is expected to be completed by calendar year 2016. Until that time, the Company is providing these media products to Haemonetics under a supply agreement. Under the terms of the APA, approximately $535,000 was paid upon closing, with the balance of the purchase price payable upon the Company’s delivery of the aforementioned blood media manufacturing capability and related assets.
	The Product Line, which was a component of the Company’s Life Sciences segment, met the criteria for discontinued operations and held for sale presentation during the third quarter of fiscal year 2012 and has been reported as a discontinued operation in the Company’s condensed consolidated financial statements. The Company did not allocate any portion of the Company’s interest expense to discontinued operations.
	The key components of discontinued operations for the three and nine months ended April 30, 2013 were as follows:
		Three Months Ended			Nine Months Ended
		Apr 30, 2013			Apr 30, 2013
	Net sales	$	344		$	8,867
	Earnings/(loss) from discontinued operations before income taxes	$	(1,896	)	$	392,425
	Provision/(benefit) for income taxes	(690		)	146,873
	Earnings/(loss) from discontinued operations, net of income taxes	$	(1,206	)	$	245,552
	Included in earnings from discontinued operations before income taxes above are a (loss)/gain on the sale of the Product Line of $(545) and $396,793, respectively, for the three and nine months ended April 30, 2013.

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Apr. 30, 2014
ACQUISITIONS [Abstract]	'
Business Combination Disclosure [Text Block]	'
	ACQUISITIONS
	During the first and second quarters of fiscal 2014, the Company completed two acquisitions - Medistad Holding BV, a European manufacturing entity, and SoloHill Engineering, Inc., a United States technology company. The aggregate consideration for these acquisitions was $30,677, which included approximately $3,000 of contingent consideration.
	On February 20, 2014, the Company acquired the Life Sciences business of ATMI, Inc. (“ATMI LifeSciences”). ATMI LifeSciences is a technology leader in the field of single-use bioprocess equipment and consumables for the biopharmaceutical and biotechnology industries. The acquisition includes the ATMI LifeSciences portfolio of custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors. The Company paid a cash purchase price of $185,000, and an additional $5,793 related to working capital adjustments.
	The acquisition of ATMI LifeSciences broadens the Company's upstream presence in bioprocessing and complements its established downstream capabilities. Combined with the aforementioned acquisitions, both innovators in the single-use market, and the Company's already solid portfolio of biopharmaceutical solutions, the addition of the ATMI LifeSciences assets well positions the Company to capitalize on opportunities in the rapidly growing single-use market segment.
	The above transactions (the “2014 acquisitions”) were funded with available cash and borrowings under the Company's commercial paper program. Tangible and intangible assets acquired and liabilities assumed were recognized based upon their estimated fair values at the respective closing dates. The Company is currently in the process of finalizing the valuations of acquired tangible and intangible assets and liabilities, and will make appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed, in the aggregate, for the 2014 acquisitions as of April 30, 2014.
	Purchase price, including working capital adjustments	$	221,470
	Cash acquired	832
	Purchase price, net of cash acquired	220,638
	Accounts receivable	10,959
	Inventories	22,299
	Other current assets	6,891
	Property, plant and equipment	30,177
	Intangible assets	86,568
	Other non-current assets	5,866
	Total identifiable assets acquired, net of cash acquired	162,760
	Current liabilities	15,722
	Non-current liabilities	26,144
	Total liabilities assumed	41,866
	Goodwill (excess cost over value of net assets acquired)	$	99,744
	The Company recorded an aggregate of $99,744 of goodwill related to the 2014 acquisitions, none of which is expected to be deductible for income tax purposes.
	The results of operations for the acquisitions since their respective acquisition dates are included in the accompanying condensed consolidated financial statements and reported in the Life Sciences segment results in Note 15, Segment Information. The impact of the 2014 acquisitions was not material, individually or in the aggregate, to the company's consolidated financial position or results from operations. Additionally, assuming these transactions had occurred at the beginning of the respective fiscal years, the consolidated pro forma results would not be materially different from reported results for the nine months ended April 30, 2014 and April 30, 2013.

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	9 Months Ended
	Apr. 30, 2014
SUBSEQUENT EVENT [Abstract]	'
Subsequent Events [Text Block]	'
	SUBSEQUENT EVENT
	On May 1, 2014, the Company acquired Filter Specialists, Inc. (“FSI”), one of the industry’s leading suppliers of filter bags. FSI has developed an extremely strong brand since being established in 1972. Their technology is a direct complement to the Company's existing product line and enables it to provide a broader and more complete portfolio of products. Additionally, this acquisition will increase the Company's footprint in the automotive paint, chemical, petrochemical, oil and gas, and food and beverage markets. On the Closing Date, the Company paid a cash purchase price of $124,000, subject to a post closing working capital adjustment.

BASIS_OF_PRESENTATION_Policies

BASIS OF PRESENTATION (Policies)	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Fair Value of Financial Instruments, Policy	'
	The Company’s money market funds and equity securities are valued using quoted market prices and, as such, are classified within Level 1 of the fair value hierarchy.
	The fair value of the Company’s investments in debt securities are valued utilizing third party pricing services and verified by management. The pricing services use inputs to determine fair value which are derived from observable market sources including reportable trades, benchmark curves, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events. These investments are included in Level 2 of the fair value hierarchy.
	The fair values of the Company’s foreign currency forward contracts are valued using pricing models, with all significant inputs derived from or corroborated by observable market data such as yield curves, currency spot and forward rates, and currency volatilities. These investments are included in Level 2 of the fair value hierarchy.
Presentation and Use of Estimates	'
	The condensed consolidated financial information of Pall Corporation and its subsidiaries (hereinafter collectively called the “Company”) included herein is unaudited. Such information reflects all adjustments of a normal recurring nature, which are, in the opinion of Company management, necessary to present fairly the Company’s consolidated financial position, results of operations and cash flows as of the dates and for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2013 (“2013 Form 10-K”).

BALANCE_SHEET_DETAILS_Tables

BALANCE SHEET DETAILS (Tables)	9 Months Ended
	Apr. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Summary of Accounts Receivable	'
		Apr 30, 2014			Jul 31, 2013
	Accounts receivable:
	Billed	$	513,137		$	508,448
	Unbilled	65,661			72,787
	Total	578,798			581,235
	Less: Allowances for doubtful accounts	(14,016		)	(14,900		)
		$	564,782		$	566,335
	Unbilled receivables principally relate to revenues accrued for long-term contracts recorded under the percentage-of-completion method of accounting.
Major Classes of Inventory	'
		Apr 30, 2014			Jul 31, 2013
	Inventory:
	Raw materials and components	$	124,837		$	94,837
	Work-in-process	109,028			94,998
	Finished goods	194,783			191,212
		$	428,648		$	381,047
Schedule of Property, Plant And Equipment	'
		Apr 30, 2014			July 31, 2013
	Property, plant and equipment:
	Property, plant and equipment	$	1,757,331		$	1,650,274
	Less: Accumulated depreciation and amortization	(958,134		)	(875,326		)
		$	799,197		$	774,948

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS (Tables)	9 Months Ended
	Apr. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill, allocated by reportable segment	'
		Life Sciences		Industrial		Total
	Balance as of July 31, 2013	$	180,896	$	161,596	$	342,492
	Acquisitions	99,744		—		99,744
	Foreign currency translation	1,818		976		2,794
	Balance as of April 30, 2014	$	282,458	$	162,572	$	445,030
Schedule of Intangible Assets	'
	Intangible assets consist of the following:
		Apr 30, 2014
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	166,112	$	64,522	$	101,590
	Customer-related intangibles	129,777		30,480		99,297
	Trademarks	16,412		6,835		9,577
	Other	3,674		2,552		1,122
		$	315,975	$	104,389	$	211,586
		Jul 31, 2013
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	123,707	$	69,992	$	53,715
	Customer-related intangibles	97,016		22,425		74,591
	Trademarks	13,291		6,166		7,125
	Other	4,425		2,613		1,812
		$	238,439	$	101,196	$	137,243

TREASURY_STOCK_Tables

TREASURY STOCK (Tables)	9 Months Ended
	Apr. 30, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Treasury Stock by Class	'
	The following table highlights the share repurchase authorizations in effect during fiscal year 2014:
		Date of Authorization
		26-Sep-11			17-Jan-13			Total
	Amount available for repurchases as of July 31, 2013	$	81,873		$	250,000		$	331,873
	New authorizations	—			—			—
	Utilized	(81,873		)	(168,127		)	(250,000		)
	Amount available for repurchases as of April 30, 2014	$	—		$	81,873		$	81,873

RESTRUCTURING_AND_OTHER_CHARGE1

RESTRUCTURING AND OTHER CHARGES, NET (Tables)	9 Months Ended
	Apr. 30, 2014
Restructuring and Related Activities [Abstract]	'
Summary of Restructuring and Other Charges	'
	The following tables summarize the restructuring and other charges (“ROTC”) recorded in the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended Apr 30, 2014									Nine Months Ended Apr 30, 2014
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	8,289		$	—		$	8,289		$	18,751		$	(402	)	$	18,349
	Professional fees and other costs, net of receipt of insurance claim payments	567			1,498			2,065			2,704			3,693			6,397
	(Gain)/loss on sale and impairment of assets, net	3,986			(1,640		)	2,346			3,986			(1,480		)	2,506
	Environmental matters	—			—			—			—			4,440			4,440
	Reversal of excess restructuring reserves	(1,158		)	—			(1,158		)	(1,782		)	—			(1,782		)
		$	11,684		$	(142	)	$	11,542		$	23,659		$	6,251		$	29,910
	Cash	$	7,698		$	(142	)	$	7,556		$	19,673		$	6,091		$	25,764
	Non-cash	3,986			—			3,986			3,986			160			4,146
		$	11,684		$	(142	)	$	11,542		$	23,659		$	6,251		$	29,910
		Three Months Ended Apr 30, 2013									Nine Months Ended Apr 30, 2013
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	5,701		$	1,452		$	7,153		$	10,896		$	2,903		$	13,799
	Professional fees and other costs, net of receipt of insurance claim payments	361			531			892			1,149			2,117			3,266
	(Gain)/loss on sale and impairment of assets, net	999			1,357			2,356			993			1,357			2,350
	Environmental matters	—			2,715			2,715			—			2,715			2,715
	Reversal of excess restructuring reserves	(292		)	—			(292		)	(633		)	—			(633		)
		$	6,769		$	6,055		$	12,824		$	12,405		$	9,092		$	21,497
	Cash	$	5,770		$	4,185		$	9,955		$	11,007		$	6,709		$	17,716
	Non-cash	999			1,870			2,869			1,398			2,383			3,781
		$	6,769		$	6,055		$	12,824		$	12,405		$	9,092		$	21,497
	(1) Restructuring:
	In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential.
	Key components of the structural cost improvement initiative include:
	•	the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,
	•	creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,
	•	reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and
	•	reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.
	Restructuring charges recorded in the three and nine months ended April 30, 2014 and April 30, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.
	Restructuring charges in the three and nine months ended April 30, 2014 also includes the impairment of assets of $3,986 related to the discontinuance of a specific manufacturing line due to excess capacity as a result of recent acquisitions.
	(2) Other (Gains)/Charges:
	Severance benefits and other employment contract obligations: In the three and nine months ended April 30, 2013, the Company recorded charges related to certain employment contract obligations.
	Professional fees and other: In the three months ended April 30, 2014, the Company recorded costs related to the settlement of a legal matter. Furthermore, in the three and nine months ended April 30, 2014, the Company recorded acquisition related legal and other professional fees. In the three and nine months ended April 30, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K).
	Gain on sale and impairment of assets: In the three months ended April 30, 2014, the Company recorded a gain on the sale of a building in Europe. In the three months ended April 30, 2013, the Company recorded an impairment related to a software project.
	Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the nine months ended April 30, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida. In the three months ended April 30, 2013, the Company increased its previously established environmental reserve related to a matter in Glen Cove, New York.
Schedule of Summarized Activity Relating to Restructuring	'
	he following table summarizes the activity related to restructuring liabilities recorded for the Company’s structural cost improvement initiative which began in fiscal year 2012:
		Severance			Other			Total
	Original charge	$	61,852		$	3,448		$	65,300
	Utilized	(27,365		)	(2,798		)	(30,163		)
	Translation	(123		)	(47		)	(170		)
	Balance at Jul 31, 2012	$	34,364		$	603		$	34,967
	Additions	21,637			2,840			24,477
	Utilized	(29,574		)	(1,936		)	(31,510		)
	Reversal of excess reserves	(500		)	(57		)	(557		)
	Translation	313			23			336
	Balance at Jul 31, 2013	$	26,240		$	1,473		$	27,713
	Additions	18,751			2,704			21,455
	Utilized	(18,996		)	(2,533		)	(21,529		)
	Reversal of excess reserves	(1,682		)	(100		)	(1,782		)
	Translation	628			63			691
	Balance at Apr 30, 2014	$	24,941		$	1,607		$	26,548
	Excluded from the table above are restructuring liabilities relating to restructuring plans initiated in fiscal year 2010. At April 30, 2014, the balance of these liabilities was $213.

COMPONENTS_OF_NET_PERIODIC_PEN1

COMPONENTS OF NET PERIODIC PENSION COST (Tables)	9 Months Ended
	Apr. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Net periodic benefit cost for the Company's defined benefit pension plans	'
	Net periodic pension benefit cost for the Company’s defined benefit pension plans includes the following components:
		Three Months Ended
		U.S. Plans						Foreign Plans						Total
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013
	Service cost	$	2,169		$	2,648		$	1,005		$	1,093		$	3,174		$	3,741
	Interest cost	3,028			2,617			4,398			3,899			7,426			6,516
	Expected return on plan assets	(2,325		)	(2,383		)	(3,611		)	(3,937		)	(5,936		)	(6,320		)
	Amortization of prior service cost/(credit)	395			392			(10		)	(12		)	385			380
	Amortization of actuarial loss	1,344			2,411			1,450			1,358			2,794			3,769
	Loss due to curtailments and settlements	—			16			—			—			—			16
	Net periodic benefit cost	$	4,611		$	5,701		$	3,232		$	2,401		$	7,843		$	8,102
		Nine Months Ended
		U.S. Plans						Foreign Plans						Total
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013			Apr 30, 2014			Apr 30, 2013
	Service cost	$	6,509		$	7,943		$	2,998		$	3,443		$	9,507		$	11,386
	Interest cost	9,083			7,852			12,923			11,965			22,006			19,817
	Expected return on plan assets	(6,974		)	(7,150		)	(10,591		)	(12,158		)	(17,565		)	(19,308		)
	Amortization of prior service cost/(credit)	1,185			1,178			(31		)	(44		)	1,154			1,134
	Amortization of actuarial loss	4,033			7,233			4,261			4,170			8,294			11,403
	Loss due to curtailments and settlements	—			49			—			—			—			49
	Net periodic benefit cost	$	13,836		$	17,105		$	9,560		$	7,376		$	23,396		$	24,481

STOCKBASED_PAYMENT_Tables

STOCK-BASED PAYMENT (Tables)	9 Months Ended
	Apr. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share Based Compensation Components of stock-based compensation expense	'
	The detailed components of stock-based compensation expense recorded in the condensed consolidated statements of earnings for the three and nine months ended April 30, 2014 and April 30, 2013 are reflected in the table below:
		Three Months Ended				Nine Months Ended
		Apr 30, 2014		Apr 30, 2013		Apr 30, 2014		Apr 30, 2013
	Restricted stock units	$	5,064	$	3,978	$	15,511	$	11,895
	Stock options	2,069		1,825		5,555		4,503
	MSPP	961		976		2,125		2,763
	ESPP	273		302		771		992
	Total	$	8,367	$	7,081	$	23,962	$	20,153

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	9 Months Ended
	Apr. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following is a reconciliation between basic shares outstanding and diluted shares outstanding:
		Three Months Ended		Nine Months Ended
		Apr 30, 2014	Apr 30, 2013	Apr 30, 2014	Apr 30, 2013
	Basic shares outstanding	110,183	111,964	110,946	112,979
	Effect of stock plans	1,283	1,347	1,269	1,436
	Diluted shares outstanding	111,466	113,311	112,215	114,415

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Apr. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of financial assets and liabilities that are measured at fair value on a recurring basis	'
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of April 30, 2014:
		Fair Value Measurements
		As of
		Apr 30, 2014		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	3,948	$	3,948	$	—	$	—
	Available-for-sale securities:
	Equity securities	4,524		4,524		—		—
	Debt securities:
	Corporate	30,359		—		30,359		—
	U.S. Treasury	10,416		—		10,416		—
	Federal agency	16,374		—		16,374		—
	Mortgage-backed	9,544		—		9,544		—
	Trading securities	788		788		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	3,555		—		3,555		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	689		—		689		—
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of July 31, 2013:
		Fair Value Measurements
		As of
		Jul 31, 2013		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	6,404	$	6,404	$	—	$	—
	Available-for-sale securities:
	Equity securities	176		176		—		—
	Debt securities:
	Corporate	32,393		—		32,393		—
	U.S. Treasury	11,543		—		11,543		—
	Federal agency	20,642		—		20,642		—
	Mortgage-backed	5,990		—		5,990		—
	Trading securities	190		190		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	301		—		301		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	3,066		—		3,066		—

INVESTMENT_SECURITIES_Tables

INVESTMENT SECURITIES (Tables)	9 Months Ended
	Apr. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Summary of the Company's available-for-sale investments by category	'
	The following is a summary of the Company’s available-for-sale investment securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets. Contractual maturity dates of debt securities held by the benefits protection trusts at April 30, 2014 range from 2014 to 2046.
		Cost/			Fair Value			Gross		Gross			Net Unrealized
		Amortized						Unrealized		Unrealized			Holding
		Cost Basis						Holding		Holding			Gains/(Losses)
								Gains		Losses
	April 30, 2014
	Equity securities	$	5,029		$	4,524		$	5	$	(510	)	$	(505	)
	Debt securities:
	Corporate	29,435			30,359			1,172		(248		)	924
	U.S. Treasury	10,310			10,416			215		(109		)	106
	Federal agency	16,075			16,374			878		(579		)	299
	Mortgage-backed	9,366			9,544			189		(11		)	178
		$	70,215		$	71,217		$	2,459	$	(1,457	)	$	1,002
	July 31, 2013
	Equity securities	$	176		$	176		$	—	$	—		$	—
	Debt securities:
	Corporate	31,546			32,393			1,274		(427		)	847
	U.S. Treasury	11,339			11,543			294		(90		)	204
	Federal agency	19,810			20,642			1,131		(299		)	832
	Mortgage-backed	5,752			5,990			238		—			238
		$	68,623		$	70,744		$	2,937	$	(816	)	$	2,121
Gross unrealized losses and fair value of Company's available-for-sale investments with unrealized losses aggregated by investment category and length of time	'
	The following table shows the gross unrealized losses and fair value of the Company’s available-for-sale investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:
		Less than 12 months						12 months or greater					Total
		Fair			Gross			Fair		Gross			Fair			Gross
		Value			Unrealized			Value		Unrealized			Value			Unrealized
					Holding					Holding						Holding
					Losses					Losses						Losses
	April 30, 2014
	Debt securities:
	Corporate	$	8,865		$	(248	)	$	—	$	—		$	8,865		$	(248	)
	U.S. Treasury	4,372			(109		)	—		—			4,372			(109		)
	Federal agency	1,634			(63		)	1,598		(516		)	3,232			(579		)
	Mortgage-backed	1,109			(11		)	—		—			1,109			(11		)
	Equity securities	4,326			(510		)	—		—			4,326			(510		)
		$	20,306		$	(941	)	$	1,598	$	(516	)	$	21,904		$	(1,457	)
		Less than 12 months						12 months or greater					Total
		Fair			Gross			Fair		Gross			Fair			Gross
		Value			Unrealized			Value		Unrealized			Value			Unrealized
					Holding					Holding						Holding
					Losses					Losses						Losses
	July 31, 2013
	Debt securities:
	Corporate	$	10,990		$	(427	)	$	—	$	—		$	10,990		$	(427	)
	U.S. Treasury	3,778			(90		)	—		—			3,778			(90		)
	Federal agency	3,701			(299		)	—		—			3,701			(299		)
		$	18,469		$	(816	)	$	—	$	—		$	18,469		$	(816	)
Proceeds and gross gains and losses from the sale of available-for-sale investments	'
	The following table shows the proceeds and gross gains and losses from the sale of available-for-sale investments for the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended						Nine Months Ended
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014		Apr 30, 2013
	Proceeds from sales	$	4,915		$	883		$	7,973	$	13,169
	Realized gross gains on sales	93			18			177		370
	Realized gross losses on sales	6			—			106		5
Trading Securities [Table Text Block]	'
	The following is a summary of the Company’s trading securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets.
		Apr 30, 2014			Jul 31, 2013
	Equity securities	$	788		$	190
	Total trading securities	$	788		$	190
	The following table shows the net gains and losses recognized on trading securities for the three and nine months ended April 30, 2014 and April 30, 2013:
		Three Months Ended						Nine Months Ended
		Apr 30, 2014			Apr 30, 2013			Apr 30, 2014		Apr 30, 2013
	Gains/(losses), net recognized for securities held	$	(1	)	$	—		$	22	$	—
	Gains/(losses), net recognized for securities sold	—			—			—		—
	Total gains/(losses), net recognized	$	(1	)	$	—		$	22	$	—

DERIVATIVE_INSTRUMENTS_AND_HED1

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Apr. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Fair values of the Company's derivative financial instruments included in the consolidated balance sheets	'
	The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows:
		Asset Derivatives						Liability Derivatives
	April 30, 2014	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	2,895			Other current liabilities		$	7
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	660			Other current liabilities		$	682
	Total derivatives			$	3,555					$	689
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	87,687
		Asset Derivatives						Liability Derivatives
	July 31, 2013	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	—			Other current liabilities		$	1,941
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	301			Other current liabilities		$	1,125
	Total derivatives			$	301					$	3,066
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	91,800
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	'
	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Three Months Ended										Three Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	305			$	1,548			Net sales		$	440		$	(615	)
										Cost of sales		171			(537		)
	Total derivatives	$	305			$	1,548					$	611		$	(1,152	)
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Nine Months Ended										Nine Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	5,615			$	(2,229	)		Net sales		$	552		$	(1,002	)
										Cost of sales		(695		)	(707		)
	Total derivatives	$	5,615			$	(2,229	)				$	(143	)	$	(1,709	)
	(a)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.
	The amounts of the gains and loss
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location	'
	The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
				Amount of Gain or (Loss) Recognized in
				Earnings on Derivatives
				Three Months Ended								Nine Months Ended
		Location of Gain or (Loss) Recognized in Earnings on Derivatives		Apr 30, 2014				Apr 30, 2013				Apr 30, 2014			Apr 30, 2013
	Derivatives not designated as hedging relationships
	Foreign exchange forward contracts	Selling, general and administrative expenses		$	(607	)		$	(5,206	)		$	(2,950	)	$	(15,032	)
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	'
	The amounts of the gains and losses related to the Company’s nonderivative financial instruments designated as hedging instruments for the three and nine months ended April 30, 2014 and April 30, 2013 are presented as follows:
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Three Months Ended										Three Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	63			$	4,320			N/A		$	—		$	—
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Nine Months Ended										Nine Months Ended
		Apr 30, 2014				Apr 30, 2013						Apr 30, 2014			Apr 30, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	(4,113	)		$	14,757			N/A		$	—		$	—
	(b)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Tables)	9 Months Ended
	Apr. 30, 2014
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	Changes in accumulated other comprehensive income by component are presented below:
		Foreign Currency Translation			Defined Benefit Pension Plan			Unrealized investment gains/(losses)			Unrealized gains/(losses) on derivatives			Accumulated other comprehensive income/(loss)
	Balance at July 31, 2013	$	84,598		$	(125,211	)	$	2,123		$	(2,302	)	$	(40,792	)
	Other comprehensive income/(loss) before reclassifications	46,330			—			(813		)	5,154			50,671
	Amounts reclassified from accumulated other comprehensive income (loss)	—			6,551			215			255			7,021
	Foreign exchange adjustments and other	—			(6,597		)	—			—			(6,597		)
	Balance at April 30, 2014	$	130,928		$	(125,257	)	$	1,525		$	3,107		$	10,303
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'
	Reclassifications out of accumulated other comprehensive income are presented below:
		Three Months Ended			Nine Months Ended			Affected line item in the Condensed Consolidated Statement of Earnings
		Apr 30, 2014			Apr 30, 2014
	Defined Benefit Pension Plan
	Amortization of prior service cost	$	(385	)	$	(1,154	)	Note (a)
	Recognized actuarial gain/(loss)	(2,794		)	(8,294		)	Note (a)
	Total before tax	(3,179		)	(9,448		)
	Tax (expense)/benefit	958			2,897
	Net of tax	$	(2,221	)	$	(6,551	)
	Unrealized investment gains/(losses)
	Realized investment gain/(losses)	$	(217	)	$	(336	)	Selling, general and administrative
	Tax (expense)/benefit	78			121
	Net of tax	$	(139	)	$	(215	)
	Unrealized gains/(losses) on derivatives
	Foreign exchange forward contracts	$	440		$	552		Sales
	Foreign exchange forward contracts	171			(695		)	Cost of sales
	Total before tax	611			(143		)
	Tax (expense)/benefit	(102		)	(112		)
	Net of tax	$	509		$	(255	)
	(a)	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	9 Months Ended
	Apr. 30, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and nine months ended April 30, 2014 and April 30, 2013.
		Three Months Ended				Nine Months Ended
		Apr 30, 2014		Apr 30, 2013		Apr 30, 2014		Apr 30, 2013
	SALES:
	Life Sciences	$	368,835	$	326,097	$	1,041,011	$	955,230
	Industrial	313,610		315,093		948,182		976,015
	Total	$	682,445	$	641,190	$	1,989,193	$	1,931,245
	SEGMENT PROFIT:
	Life Sciences	$	88,339	$	81,195	$	252,240	$	233,514
	Industrial	49,350		45,853		146,723		146,723
	Total segment profit	137,689		127,048		398,963		380,237
	Corporate Services Group	17,304		15,172		48,034		47,263
	ROTC	11,542		12,824		29,910		21,497
	Interest expense, net	4,747		5,298		15,919		10,747
	Earnings from continuing operations before income taxes	$	104,096	$	93,754	$	305,100	$	300,730

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS (Tables)	9 Months Ended
	Apr. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures	'
	The key components of discontinued operations for the three and nine months ended April 30, 2013 were as follows:
		Three Months Ended			Nine Months Ended
		Apr 30, 2013			Apr 30, 2013
	Net sales	$	344		$	8,867
	Earnings/(loss) from discontinued operations before income taxes	$	(1,896	)	$	392,425
	Provision/(benefit) for income taxes	(690		)	146,873
	Earnings/(loss) from discontinued operations, net of income taxes	$	(1,206	)	$	245,552
	Included in earnings from discontinued operations before income taxes above are a (loss)/gain on the sale of the Product Line of $(545) and $396,793, respectively, for the three and nine months ended April 30, 2013.

ACQUISITIONS_Tables

ACQUISITIONS (Tables)	9 Months Ended
	Apr. 30, 2014
ACQUISITIONS [Abstract]	'
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	'
	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed, in the aggregate, for the 2014 acquisitions as of April 30, 2014.
	Purchase price, including working capital adjustments	$	221,470
	Cash acquired	832
	Purchase price, net of cash acquired	220,638
	Accounts receivable	10,959
	Inventories	22,299
	Other current assets	6,891
	Property, plant and equipment	30,177
	Intangible assets	86,568
	Other non-current assets	5,866
	Total identifiable assets acquired, net of cash acquired	162,760
	Current liabilities	15,722
	Non-current liabilities	26,144
	Total liabilities assumed	41,866
	Goodwill (excess cost over value of net assets acquired)	$	99,744

BALANCE_SHEET_DETAILS_Details

BALANCE SHEET DETAILS (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Receivables [Abstract]	'	'
Billed	$513,137	$508,448
Unbilled	65,661	72,787
Total	578,798	581,235
Less: Allowances for doubtful accounts	-14,016	-14,900
Accounts receivable	$564,782	$566,335

BALANCE_SHEET_DETAILS_Details_

BALANCE SHEET DETAILS (Details 1) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Inventory, Net [Abstract]	'	'
Raw materials and components	$124,837	$94,837
Work-in-process	109,028	94,998
Finished goods	194,783	191,212
Inventory	$428,648	$381,047

BALANCE_SHEET_DETAILS_Details_1

BALANCE SHEET DETAILS (Details 2) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Abstract]	'	'
Property, plant and equipment	$1,757,331	$1,650,274
Less: Accumulated depreciation and amortization	-958,134	-875,326
Property, plant and equipment	$799,197	$774,948

GOODWILL_AND_INTANGIBLE_ASSETS2

GOODWILL AND INTANGIBLE ASSETS (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	$342,492
Acquisitions	99,744
Foreign currency translation	2,794
Goodwill, Ending Balance	445,030
Life Sciences [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	180,896
Acquisitions	99,744
Foreign currency translation	1,818
Goodwill, Ending Balance	282,458
Industrial [Member]	'
Goodwill [Roll Forward]	'
Goodwill, Beginning Balance	161,596
Acquisitions	0
Foreign currency translation	976
Goodwill, Ending Balance	$162,572

GOODWILL_AND_INTANGIBLE_ASSETS3

GOODWILL AND INTANGIBLE ASSETS (Details 1) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	$315,975	$238,439
Accumulated Amortization	104,389	101,196
Net	211,586	137,243
Patents and unpatented technology [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	166,112	123,707
Accumulated Amortization	64,522	69,992
Net	101,590	53,715
Customer-related intangibles [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	129,777	97,016
Accumulated Amortization	30,480	22,425
Net	99,297	74,591
Trademarks [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	16,412	13,291
Accumulated Amortization	6,835	6,166
Net	9,577	7,125
Other [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	3,674	4,425
Accumulated Amortization	2,552	2,613
Net	$1,122	$1,812

GOODWILL_AND_INTANGIBLE_ASSETS4

GOODWILL AND INTANGIBLE ASSETS (Details Textuals) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'	'
Amortization expense for Intangible assets	$5,399	$4,765	$14,778	$14,900
Estimated amortization expense for intangible assets, remainder of 2014	5,699	'	5,699	'
Estimated amortization expense for intangible assets, 2015	21,202	'	21,202	'
Estimated amortization expense for intangible assets, 2016	19,920	'	19,920	'
Estimated amortization expense for intangible assets, 2017	19,841	'	19,841	'
Estimated amortization expense for intangible assets, 2018	19,670	'	19,670	'
Estimated amortization expense for intangible assets, 2019	$17,316	'	$17,316	'

TREASURY_STOCK_Details

TREASURY STOCK (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Jul. 31, 2013
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	$81,873	$331,873
New authorizations	0	'
Utilized	250,000	'
Amount available for repurchases as of April 30, 2014	81,873	331,873
September 26, 2011 Authorization [Member]	'	'
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	0	81,873
New authorizations	0	'
Utilized	81,873	'
Amount available for repurchases as of April 30, 2014	0	81,873
January 17, 2013 Authorization [Member]	'	'
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	81,873	250,000
New authorizations	0	'
Utilized	168,127	'
Amount available for repurchases as of April 30, 2014	$81,873	$250,000

TREASURY_STOCK_Detail_Textuals

TREASURY STOCK (Detail Textuals) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Apr. 30, 2014
Accelerated Share Repurchases [Line Items]	'
Utilized	$250,000
Shares issued for stock plans	935
Treasury stock, shares	18,291
September 2013 Accelerated Share Repurchase [Member]	'
Accelerated Share Repurchases [Line Items]	'
Utilized	125,000
Treasury Stock, Shares, Acquired	1,573
Accelerated Share Repurchases, Final Price Paid Per Share	$79.45
December 2013 Accelerated Share Repurchase [Member]	'
Accelerated Share Repurchases [Line Items]	'
Utilized	$125,000
Treasury Stock, Shares, Acquired	1,483
Accelerated Share Repurchases, Final Price Paid Per Share	$84.31

CONTINGENCIES_AND_COMMITMENTS_

CONTINGENCIES AND COMMITMENTS (Details Textuals) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014
Site Contingency [Line Items]	'
Environmental liabilities	$20,738
Pinellas Park Site [Member]	'
Site Contingency [Line Items]	'
Environmental matters	$4,440

RESTRUCTURING_AND_OTHER_CHARGE2

RESTRUCTURING AND OTHER CHARGES, NET (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014		Apr. 30, 2013		Apr. 30, 2014		Apr. 30, 2013
Restructuring Charges [Abstract]	'		'		'		'
Severance benefits and other employment contract obligations	$8,289	[1]	$5,701	[1]	$18,751	[1]	$10,896	[1]
Professional fees and other costs, net of receipt of insurance claim payments	567	[1]	361	[1]	2,704	[1]	1,149	[1]
(Gain)/loss on sale and impairment of assets, net	-3,986	[1]	-999	[1]	-3,986	[1]	-993	[1]
Reversal of excess restructuring reserves	-1,158	[1]	-292		-1,782	[1]	-633
Restructuring Charges	11,684	[1]	6,769	[1]	23,659	[1]	12,405	[1]
Cash	7,698	[1]	5,770	[1]	19,673	[1]	11,007	[1]
Non-cash	3,986	[1]	999	[1]	3,986	[1]	1,398	[1]
Other Gains (Charges) [Abstract]	'		'		'		'
Severance benefits and other employment contract obligations	0	[2]	-1,452	[2]	402	[2]	-2,903	[2]
Professional fees and other costs, net of receipt of insurance claim payments	-1,498	[2]	-531	[2]	-3,693	[2]	-2,117	[2]
(Gain)/loss on sale and impairment of assets, net	1,640	[2]	-1,357	[2]	1,480	[2]	-1,357	[2]
Environmental matters	'		2,715	[2]	4,440	[2]	2,715	[2]
Other (Gains) Charges	-142	[2]	6,055	[2]	6,251	[2]	9,092	[2]
Cash	-142	[2]	4,185	[2]	6,091	[2]	6,709	[2]
Non-cash	0	[2]	-1,870	[2]	-160	[2]	-2,383	[2]
Restructuring Charges and Other Gains (Charges) [Abstract]	'		'		'		'
Severance benefits and other employment contract obligations	-8,289		-7,153		-18,349		-13,799
Professional fees and other costs, net of receipt of insurance claim payments	-2,065		-892		-6,397		-3,266
(Gain)/loss on sale and impairment of assets, net	-2,346		-2,356		-2,506		-2,350
Environmental matters	'		2,715	[2]	4,440	[2]	2,715	[2]
Restructuring And Other Gains (Charges)	11,542		12,824		29,910		21,497
Cash	7,556		9,955		25,764		17,716
Non-cash	$3,986		$2,869		$4,146		$3,781
[1]	Restructuring:In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential. Key components of the structural cost improvement initiative include:•the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,•creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,•reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and•reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.Restructuring charges recorded in the three and nine months ended April 30, 2014 and April 30, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.Restructuring charges in the three and nine months ended April 30, 2014 also includes the impairment of assets of $3,986 related to the discontinuance of a specific manufacturing line due to excess capacity as a result of recent acquisitions.
[2]	Other (Gains)/Charges:Severance benefits and other employment contract obligations: In the three and nine months ended April 30, 2013, the Company recorded charges related to certain employment contract obligations.Professional fees and other: In the three months ended April 30, 2014, the Company recorded costs related to the settlement of a legal matter. Furthermore, in the three and nine months ended April 30, 2014, the Company recorded acquisition related legal and other professional fees. In the three and nine months ended April 30, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K).Gain on sale and impairment of assets: In the three months ended April 30, 2014, the Company recorded a gain on the sale of a building in Europe. In the three months ended April 30, 2013, the Company recorded an impairment related to a software project. Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the nine months ended April 30, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida. In the three months ended April 30, 2013, the Company increased its previously established environmental reserve related to a matter in Glen Cove, New York.

RESTRUCTURING_AND_OTHER_CHARGE3

RESTRUCTURING AND OTHER CHARGES, NET (Details 1) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Apr. 30, 2014

Apr. 30, 2013

Apr. 30, 2014

Apr. 30, 2013

Apr. 30, 2014

Jul. 31, 2013

Jul. 31, 2012

Apr. 30, 2014

Jul. 31, 2013

Jul. 31, 2012

Apr. 30, 2014

Jul. 31, 2013

Jul. 31, 2012

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Employee Severance [Member]

Employee Severance [Member]

Employee Severance [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Restructuring Reserve [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

Original charge

$11,684

[1]

$6,769

[1]

$23,659

[1]

$12,405

[1]

'

'

$65,300

'

'

$61,852

'

'

$3,448

Utilized

'

'

'

'

21,529

31,510

30,163

18,996

29,574

27,365

2,533

1,936

2,798

Translation

'

'

'

'

691

336

-170

628

313

-123

63

23

-47

Restructuring Reserve, Beginning Balance

'

'

'

'

27,713

34,967

'

26,240

34,364

'

1,473

603

'

Additions

'

'

'

'

21,455

24,477

'

18,751

21,637

'

2,704

2,840

'

Reversal of excess reserves

1,158

[1]

292

1,782

[1]

633

-1,782

-557

'

-1,682

-500

'

-100

-57

'

Restructuring Reserve, Ending Balance

'

'

'

'

$26,548

$27,713

$34,967

$24,941

$26,240

$34,364

$1,607

$1,473

$603

[1]

Restructuring:In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential. Key components of the structural cost improvement initiative include:•the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,•creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,•reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and•reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.Restructuring charges recorded in the three and nine months ended April 30, 2014 and April 30, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.Restructuring charges in the three and nine months ended April 30, 2014 also includes the impairment of assets of $3,986 related to the discontinuance of a specific manufacturing line due to excess capacity as a result of recent acquisitions.

RESTRUCTURING_AND_OTHER_CHARGE4

RESTRUCTURING AND OTHER CHARGES, NET (Details Textuals) (Restructuring Liability 2009 And 2010 [Member], USD $)	Apr. 30, 2014
In Thousands, unless otherwise specified
Restructuring Liability 2009 And 2010 [Member]	'
Restructuring and other gains charges [Line Items]	'
Restructuring Reserve, Ending Balance	$213

INCOME_TAXES_Details_Textuals

INCOME TAXES (Details Textuals) (USD $)	9 Months Ended			9 Months Ended		1 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Jul. 31, 2013	Apr. 30, 2013	Apr. 30, 2014	31-May-14
				Internal Revenue Service (IRS) [Member]	Foreign Tax Authority [Member]	Subsequent Event [Member]
						Foreign Tax Authority [Member]
Income Tax Examination [Line Items]	'	'	'	'	'	'
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority	'	'	'	$10,193	$10,961	$7,000
Reversal of Interest Due to Audit Settlement	'	'	'	6,704	1,478	3,000
Reversal of Interest, Net of Income Tax, Due to Audit Settlement	'	'	'	4,268	1,138	'
Effective Income Tax Rate, Continuing Operations	20.10%	18.90%	'	'	'	'
Discrete Tax Item	10,054	7,757	'	'	'	'
Unrecognized Tax Benefits	198,899	'	203,376	'	'	'
Unrecognized Tax Benefits, Period Increase (Decrease)	4,477	'	'	'	'	'
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	155,469	'	'	'	'	'
Income Tax Examination, Penalties and Interest Accrued	17,450	'	18,622	'	'	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound	0	'	'	'	'	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound	$55,781	'	'	'	'	'

COMPONENTS_OF_NET_PERIODIC_PEN2

COMPONENTS OF NET PERIODIC PENSION COST (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	$3,174	$3,741	$9,507	$11,386
Interest cost	7,426	6,516	22,006	19,817
Expected return on plan assets	-5,936	-6,320	-17,565	-19,308
Amortization of prior service cost/(credit)	385	380	1,154	1,134
Amortization of actuarial loss	2,794	3,769	8,294	11,403
Loss due to curtailments and settlements	0	16	0	49
Net periodic benefit cost	7,843	8,102	23,396	24,481
U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	2,169	2,648	6,509	7,943
Interest cost	3,028	2,617	9,083	7,852
Expected return on plan assets	-2,325	-2,383	-6,974	-7,150
Amortization of prior service cost/(credit)	395	392	1,185	1,178
Amortization of actuarial loss	1,344	2,411	4,033	7,233
Loss due to curtailments and settlements	0	16	0	49
Net periodic benefit cost	4,611	5,701	13,836	17,105
Foreign Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	1,005	1,093	2,998	3,443
Interest cost	4,398	3,899	12,923	11,965
Expected return on plan assets	-3,611	-3,937	-10,591	-12,158
Amortization of prior service cost/(credit)	-10	-12	-31	-44
Amortization of actuarial loss	1,450	1,358	4,261	4,170
Loss due to curtailments and settlements	0	0	0	0
Net periodic benefit cost	$3,232	$2,401	$9,560	$7,376

STOCKBASED_PAYMENT_Details

STOCK-BASED PAYMENT (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Share Based Employee and Director Compensation Award Types	4	'	4	'
Allocated Share-based Compensation Expense	$8,367	$7,081	$23,962	$20,153
Restricted stock units [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	5,064	3,978	15,511	11,895
Stock options [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	2,069	1,825	5,555	4,503
Management Stock Purchase Plan [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	961	976	2,125	2,763
Employee Stock [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	$273	$302	$771	$992

EARNINGS_PER_SHARE_Details

EARNINGS PER SHARE (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]	'	'	'	'
Basic shares outstanding	110,183	111,964	110,946	112,979
Effect of stock plans	1,283	1,347	1,269	1,436
Diluted shares outstanding	111,466	113,311	112,215	114,415

EARNINGS_PER_SHARE_Details_Tex

EARNINGS PER SHARE (Details Textuals)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Employee stock options and restricted stock units which were not included in the computation of diluted shares	496	742	524	586

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Available-for-sale securities:	'	'
Securities	$71,217	$70,744
Trading Securities [Abstract]	'	'
Trading Securities	788	190
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	788	190
Derivative financial instruments:	'	'
Foreign exchange forward contracts	3,555	301
Derivative financial instruments:	'	'
Foreign exchange forward contracts	689	3,066
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	4,524	176
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	30,359	32,393
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	10,416	11,543
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	16,374	20,642
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	9,544	5,990
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	788	190
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	4,524	176
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	3,555	301
Derivative financial instruments:	'	'
Foreign exchange forward contracts	689	3,066
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	30,359	32,393
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	10,416	11,543
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	16,374	20,642
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	9,544	5,990
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	3,948	6,404
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	3,948	6,404
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	0	0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	$0	$0

INVESTMENT_SECURITIES_Details

INVESTMENT SECURITIES (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Cost/ Amortized Cost Basis	$70,215	$68,623
Fair Value	71,217	70,744
Gross Unrealized Holding Gains	2,459	2,937
Gross Unrealized Holding Losses	-1,457	-816
Net Unrealized Holding Gains/(Losses)	1,002	2,121
Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Equity Securities, Cost/Amortized Cost Basis	5,029	176
Equity Securities, Fair Value	4,524	176
Equity Securities, Gross Unrealized Holding Gains	5	0
Equity Securities, Gross Unrealized Holdings Losses	-510	0
Equity Securities, Net Unrealized Holding Gains/(Losses)	-505	0
Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	29,435	31,546
Debt Securities, Fair Value	30,359	32,393
Debt Securities, Gross Unrealized Holding Gains	1,172	1,274
Debt Securities, Gross Unrealized Holdings Losses	-248	-427
Debt Securities, Net Unrealized Holding Gains/(Losses)	924	847
U.S. Treasury [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	10,310	11,339
Debt Securities, Fair Value	10,416	11,543
Debt Securities, Gross Unrealized Holding Gains	215	294
Debt Securities, Gross Unrealized Holdings Losses	-109	-90
Debt Securities, Net Unrealized Holding Gains/(Losses)	106	204
Federal Agency [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	16,075	19,810
Debt Securities, Fair Value	16,374	20,642
Debt Securities, Gross Unrealized Holding Gains	878	1,131
Debt Securities, Gross Unrealized Holdings Losses	-579	-299
Debt Securities, Net Unrealized Holding Gains/(Losses)	299	832
Mortgage-backed [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	9,366	5,752
Debt Securities, Fair Value	9,544	5,990
Debt Securities, Gross Unrealized Holding Gains	189	238
Debt Securities, Gross Unrealized Holdings Losses	-11	0
Debt Securities, Net Unrealized Holding Gains/(Losses)	$178	$238

INVESTMENT_SECURITIES_Details_

INVESTMENT SECURITIES (Details 1) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	$20,306	$18,469
Less than 12 months, Gross Unrealized Holding Losses	-941	-816
12 months or greater, Fair Value	1,598	0
12 months or greater, Gross Unrealized Holding Losses	-516	0
Total, Fair Value	21,904	18,469
Total, Gross Unrealized Holding Losses	-1,457	-816
Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	8,865	10,990
Less than 12 months, Gross Unrealized Holding Losses	-248	-427
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	8,865	10,990
Total, Gross Unrealized Holding Losses	-248	-427
U.S. Treasury [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	4,372	3,778
Less than 12 months, Gross Unrealized Holding Losses	-109	-90
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	4,372	3,778
Total, Gross Unrealized Holding Losses	-109	-90
Federal Agency [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	1,634	3,701
Less than 12 months, Gross Unrealized Holding Losses	-63	-299
12 months or greater, Fair Value	1,598	0
12 months or greater, Gross Unrealized Holding Losses	-516	0
Total, Fair Value	3,232	3,701
Total, Gross Unrealized Holding Losses	-579	-299
Mortgage-backed [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	1,109	'
Less than 12 months, Gross Unrealized Holding Losses	-11	'
12 months or greater, Fair Value	0	'
12 months or greater, Gross Unrealized Holding Losses	0	'
Total, Fair Value	1,109	'
Total, Gross Unrealized Holding Losses	-11	'
Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	4,326	'
Less than 12 months, Gross Unrealized Holding Losses	-510	'
12 months or greater, Fair Value	0	'
12 months or greater, Gross Unrealized Holding Losses	0	'
Total, Fair Value	4,326	'
Total, Gross Unrealized Holding Losses	($510)	'

INVESTMENT_SECURITIES_Details_1

INVESTMENT SECURITIES (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Investments, Debt and Equity Securities [Abstract]	'	'	'	'
Proceeds from sales	$4,915	$883	$7,973	$13,169
Realized gross gains on sales	93	18	177	370
Realized gross losses on sales	$6	$0	$106	$5

INVESTMENT_SECURITIES_Details_2

INVESTMENT SECURITIES (Details 3) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013	Jul. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'	'	'	'	'
Equity securities	$788	'	$788	'	$190
Total trading securities	788	'	788	'	190
Gains/(losses), net recognized for securities held	-1	0	22	0	'
Gains/(losses), net recognized for securities sold	0	0	0	0	'
Total gains/(losses), net recognized	($1)	$0	$22	$0	'

DERIVATIVE_INSTRUMENTS_AND_HED2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details Textuals)	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014	Apr. 30, 2014
	Foreign Exchange Contract [Member]	Not Designated as Hedging Instrument [Member]	Not Designated as Hedging Instrument [Member]	Designated as Hedging Instrument [Member]	Designated as Hedging Instrument [Member]	Unsecured Debt [Member]
	USD ($)	Foreign Exchange Contract [Member]	Foreign Exchange Contract [Member]	Cash Flow Hedging [Member]	Cash Flow Hedging [Member]	Jpy Loan Due Fiscal Year 2015 [Member]
		USD ($)	USD ($)	Foreign Exchange Contract [Member]	Foreign Exchange Contract [Member]	JPY (¥)
				USD ($)	USD ($)
Derivative [Line Items]	'	'	'	'	'	'
Derivative, Notional Amount	$512,733,000	$406,572,000	$406,572,000	$106,161,000	$106,161,000	'
Foreign Currency Derivatives at Fair Value, Net	2,866,000	'	'	'	'	'
Debt Instrument, Face Amount	'	'	'	'	'	9,000,000,000
Derivative, Notional Amount Entered During Period	'	$664,039,000	$1,845,481,000	$23,174,000	$77,941,000	'

DERIVATIVE_INSTRUMENTS_AND_HED3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) (USD $)	Apr. 30, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Foreign Exchange Contract [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	$3,555	$301
Foreign Exchange Contract [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	689	3,066
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	2,895	0
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	7	1,941
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	660	301
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	682	1,125
Net Investment Hedging [Member] | Long-term Debt [Member]	'	'
Nonderivative instruments designated as hedging instruments	'	'
Debt Instrument, Fair Value Disclosure	$87,687	$91,800

DERIVATIVE_INSTRUMENTS_AND_HED4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 1) (Designated as Hedging Instrument [Member], Foreign Exchange Contract [Member], Cash Flow Hedging [Member], USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014		Apr. 30, 2013		Apr. 30, 2014		Apr. 30, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	$611	[1]	($1,152)	[1]	($143)	[1]	($1,709)	[1]
Sales [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	440	[1]	-615	[1]	552	[1]	-1,002	[1]
Cost of Sales [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	171	[1]	-537	[1]	-695	[1]	-707	[1]
Other Comprehensive Income (Loss) [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	$305		$1,548		$5,615		($2,229)
[1]	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.

DERIVATIVE_INSTRUMENTS_AND_HED5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 2) (Not Designated as Hedging Instrument [Member], Foreign Exchange Contract [Member], Selling, General and Administrative Expenses [Member], USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Selling, General and Administrative Expenses [Member]	'	'	'	'
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'	'
Derivative, Gain (Loss) on Derivative, Net	($607)	($5,206)	($2,950)	($15,032)

DERIVATIVE_INSTRUMENTS_AND_HED6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 3) (Net Investment Hedging [Member], USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014		Apr. 30, 2013		Apr. 30, 2014		Apr. 30, 2013
Net Investment Hedging [Member]	'		'		'		'
Nonderivatives designated as hedging relationships	'		'		'		'
Nonderivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion	$63		$4,320		($4,113)		$14,757
Nonderivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion	$0	[1]	$0	[1]	$0	[1]	$0	[1]
[1]	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and nine months ended April 30, 2014 and April 30, 2013.

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	($40,792)
Other comprehensive income/(loss) before reclassifications	50,671
Amounts reclassified from accumulated other comprehensive income (loss)	7,021
Foreign exchange adjustments and other	-6,597
Balance at April 30, 2014	10,303
Foreign Currency Translation [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	84,598
Other comprehensive income/(loss) before reclassifications	46,330
Amounts reclassified from accumulated other comprehensive income (loss)	0
Balance at April 30, 2014	130,928
Defined Benefit Pension Plan [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	-125,211
Other comprehensive income/(loss) before reclassifications	0
Amounts reclassified from accumulated other comprehensive income (loss)	6,551
Foreign exchange adjustments and other	-6,597
Balance at April 30, 2014	-125,257
Unrealized investment gains/(losses) [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	2,123
Other comprehensive income/(loss) before reclassifications	-813
Amounts reclassified from accumulated other comprehensive income (loss)	215
Balance at April 30, 2014	1,525
Unrealized gains/(losses) on derivatives [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	-2,302
Other comprehensive income/(loss) before reclassifications	5,154
Amounts reclassified from accumulated other comprehensive income (loss)	255
Balance at April 30, 2014	$3,107

ACCUMULATED_OTHER_COMPREHENSIV3

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Details 1) (USD $)	3 Months Ended			9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014		Apr. 30, 2013	Apr. 30, 2014		Apr. 30, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Total before tax	$104,096		$93,754	$305,100		$300,730
Realized investment gain/(losses)	-201,045		-199,595	-592,228		-601,569
Tax (expense)/benefit	-15,405		-19,483	-61,230		-56,975
Net of tax	88,691		73,065	243,870		489,307
Foreign exchange forward contracts	682,445		641,190	1,989,193		1,931,245
Foreign exchange forward contracts	-334,371		-307,111	-971,146		-928,120
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Amortization of prior service cost	-385	[1]	'	-1,154	[1]	'
Recognized actuarial gain/(loss)	-2,794	[1]	'	-8,294	[1]	'
Total before tax	-3,179		'	-9,448		'
Tax (expense)/benefit	958		'	2,897		'
Net of tax	-2,221		'	-6,551		'
Accumulated Net Unrealized Investment Gain (Loss) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Realized investment gain/(losses)	-217		'	-336		'
Tax (expense)/benefit	78		'	121		'
Net of tax	-139		'	-215		'
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Total before tax	611		'	-143		'
Tax (expense)/benefit	-102		'	-112		'
Net of tax	509		'	-255		'
Foreign Exchange Contract [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Foreign exchange forward contracts	440		'	552		'
Foreign exchange forward contracts	$171		'	($695)		'
[1]	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	$682,445	$641,190	$1,989,193	$1,931,245
Operating Income (Loss) [Abstract]	'	'	'	'
ROTC	11,542	12,824	29,910	21,497
Interest expense, net	4,747	5,298	15,919	10,747
Earnings from continuing operations before income taxes	104,096	93,754	305,100	300,730
Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	-137,689	-127,048	-398,963	-380,237
Corporate, Non-Segment [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	17,304	15,172	48,034	47,263
Segment Reconciling Items [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
ROTC	11,542	12,824	29,910	21,497
Interest expense, net	4,747	5,298	15,919	10,747
Life Sciences Segment [Member]	'	'	'	'
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	368,835	326,097	1,041,011	955,230
Life Sciences Segment [Member] | Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	-88,339	-81,195	-252,240	-233,514
Industrial Segment [Member]	'	'	'	'
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	313,610	315,093	948,182	976,015
Industrial Segment [Member] | Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	($49,350)	($45,853)	($146,723)	($146,723)

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Details Textual) (Product Line [Member], USD $)	1 Months Ended	3 Months Ended	9 Months Ended
	Aug. 31, 2012	Apr. 30, 2013	Apr. 30, 2013	Apr. 28, 2012
	employee
Product Line [Member]	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Expected proceeds from divestiture of component	'	'	'	$550,000,000
Number of employees to be transferred	1,400	'	'	'
Proceeds From divestiture of component	535,000,000	'	'	'
Gain (loss) on the sale of product line	'	($545,000)	$396,793,000	'

DISCONTINUED_OPERATIONS_Detail1

DISCONTINUED OPERATIONS (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014	Apr. 30, 2013	Apr. 30, 2014	Apr. 30, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Earnings/(loss) from discontinued operations, net of income taxes	$0	($1,206)	$0	$245,552
Product Line [Member]	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Net sales	'	344	'	8,867
Earnings/(loss) from discontinued operations before income taxes	'	-1,896	'	392,425
Provision/(benefit) for income taxes	'	-690	'	146,873
Earnings/(loss) from discontinued operations, net of income taxes	'	($1,206)	'	$245,552

ACQUISITIONS_Details

ACQUISITIONS (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Apr. 30, 2014
Business Acquisition [Line Items]	'
Purchase price, including working capital adjustments	$221,470
Cash acquired	832
Purchase price, net of cash acquired	220,638
Accounts receivable	10,959
Inventories	22,299
Other current assets	6,891
Property, plant and equipment	30,177
Intangible assets	86,568
Other non-current assets	5,866
Total identifiable assets acquired, net of cash acquired	162,760
Current liabilities	15,722
Non-current liabilities	26,144
Total liabilities assumed	41,866
Goodwill (excess cost over value of net assets acquired)	$99,744

ACQUISITIONS_Details_Textuals

ACQUISITIONS (Details Textuals) (USD $)	3 Months Ended	9 Months Ended
	Apr. 30, 2014	Apr. 30, 2014
Business Acquisition [Line Items]	'	'
Goodwill (excess cost over value of net assets acquired)	'	99,744,000
Medistad [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Name of Acquired Entity	'	'Medistad Holding BV
SoloHill [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Name of Acquired Entity	'	'SoloHill Engineering
Contingent Consideration	3,000,000	3,000,000
Medistad and Solohill [Member]	'	'
Business Acquisition [Line Items]	'	'
Purchase price, net of cash acquired	'	30,677,000
ATMI LifeSciences [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Name of Acquired Entity	'	'ATMI LifeSciences
Payments to Acquire Businesses, Gross	185,000,000	'
Working Capital Adjustments	$5,793,000	'

SUBSEQUENT_EVENT_Details

SUBSEQUENT EVENT (Details) (Filter Specialists, Inc. [Member], Subsequent Event [Member], USD $)	0 Months Ended
In Thousands, unless otherwise specified	1-May-14
Filter Specialists, Inc. [Member] | Subsequent Event [Member]	'
Subsequent Event [Line Items]	'
Payments to Acquire Businesses, Gross	$124,000